BUZZ-India's Glenmark Pharma rises on settling anti-trust lawsuit with plaintiffs

Shares of Glenmark Pharmaceuticals GLEN.NS up ~4% to 1350.5 rupees

Co settles remaining antitrust and consumer protection lawsuits with three plaintiffs in connection with generic cholesterol drug Zetia

Plaintiffs include Humana HUM.N, Centene Corp CNC.N

and Kaiser Foundation Health Plan [RIC:RIC:KISERF.UL]

Under terms of $7 mln settlement, Glenmark denies allegations by plaintiffs, concedes no liability

Including session's gains, GLEN shares up 48.3% in the last 12 months